STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1155 by analyst upside · 2026-06-27
ZTS
Zoetis Inc.
Healthcare · Market Cap $32B · P/E 12.5x
ANALYST PRICE TARGET
+63.7%
implied upside to consensus target
Current Price $76.09
Consensus Target $124.59
Bull Target $160.0
Bear Target $90.0
Analysts Covering 17
ANALYST CONSENSUS — BUY
Strong Buy
3
Buy
7
Hold
8
Sell
0
52-Week Low $72.38
52-Week High $161.77
YTD Return -39.1%
FUNDAMENTALS
Market Cap $32B
P/E Ratio (TTM) 12.5x
Forward P/E 10.3x
EPS (TTM) $6.10
PEG Ratio 1.87
Dividend Yield 2.72%
Revenue (TTM) $9.5B
Profit Margin 28.0%
52-WEEK RANGE
52-Week Low $72.38
52-Week High $161.77
Current Price $76.09
Bear Target $90.0
Bull Target $160.0
● Now $76.09 ● Target $124.59
TRADING DATA
Avg Volume 6.4M
YTD Return -39.1%
Analyst Count 17
Consensus Buy
Upside to Target +63.7%
Last Updated 2026-06-27

ANALYST SUMMARY

Zoetis Inc. (ZTS) is currently trading at $76.09 with a Wall Street consensus price target of $124.59, implying potential upside of 63.7% over the next 12 months. 17 analysts currently cover ZTS, with a consensus rating of Buy — 56% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $160.0, while the most cautious has a target of $90.0.

ZTS operates in the Healthcare sector with a market capitalisation of $32B. The stock is down 39.1% year-to-date and is currently trading near the lower end of its 52-week range of $72.38 – $161.77.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for ZTS, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Argus Research ↓ Downgrade
Buy → Hold 2026-05-27 Building track record
Stifel — Reiterated
Hold → Hold 2026-05-22 Building track record
Citigroup — Reiterated
Buy → Buy 2026-05-18 Building track record
UBS — Reiterated
Neutral → Neutral 2026-05-08 33% win rate (6 calls)
JP Morgan — Reiterated
Overweight → Overweight 2026-05-08 43% win rate (7 calls)
UBS — Reiterated
Neutral → Neutral 2026-04-28 33% win rate (6 calls)
Citigroup ● Initiated
Buy 2026-04-15 Building track record
B of A Securities — Reiterated
Neutral → Neutral 2026-02-13 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
41
out of 100
Coverage depth
22/30
Consensus clarity
12/30
Vote unanimity
5/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →